Abstract:OBJECTIVE: Produce offspring from parthegenotes to demonstrate their pluripotency, and test whether activated eggs can contribute to all tissues, and therefore provide a valuable source of cells for regenerative medicine. Women facing cancer therapy or combat could benefit from pluripotent cells for regenerative medicine. Parthenogenetic embryonic stem (pES) cells produced from activated eggs avoid ethical constraints, but their digyneic origin raises concerns about abnormal imprinting, including hypomorphic placenta and limited contributions to some fetal tissues. In vitro maturation (IVM) disrupts imprinting, so paradoxically may help erase digyneic imprinting of parthenogenetic embryos. Also, stem cells undergo extensive epigenetic reprogramming, and tetraploid complementation can furnish a placenta to support development and differentiation of pES cells to pups. DESIGN: Laboratory-based mouse study. MATERIALS AND METHODS: IVM-produced B6C3F1 mouse eggs were activated with strontium, cultured to blastocyts, pES cells produced and characterized, injected into KM tetraploid embryos, transferred to ICR surrogates, and the contribution of pES cells to tissues in resulting pups studied. PCR analysis of DNA microsatellites and allele heterozygosity determined the pups' origin. RESULTS: pES cells were Oct 4, SSEA-1, AP, TERT, Nanog postive, karyotypically normal and produced teratomas in nude mice. We produced for the first time term pups from parthenogenesis by using IVM eggs and tetraploid complementation. Microsatellite and heterozygoisity analyses confirmed the pES cell origin of all pups. CONCLUSIONS: Epigenetic reprogramming from IVM and passage through the stem cell state overcome digyneic imprinting, and tetraploid complementation furnishes placentas to produce term pups from pES cells. This does not justify fatherless reproduction, but does suggest that pES cells may provide a valuable and ethically justifiable source of private pluripotent cells.

Viable offspring derived from single unfertilized mammalian oocytes

Generation of developmentally competent oocytes and fertile mice from parthenogenetic embryonic stem cells

Generation and characterization of mouse parthenogenetic embryonic stem cells containing genomes from non-growing and fully grown oocytes.

High-frequency generation of viable mice from engineered bi-maternal embryos

Transplantation of Male Pronucleus Derived from in Vitro Fertilization of Enucleated Oocyte into Parthenogenetically Activated Oocyte Results in Live Offspring in Mouse.

Live offspring produced by mouse oocytes derived from premeiotic fetal germ cells.

DNA Methylation Analysis and Editing in Single Mammalian Oocytes.

Parthenogenetic Babies from IVM Eggs and Tetraploid Complementation

In vitro germline potential of stem cells derived from fetal porcine skin.

The Genetic Program of Oocytes Can Be Modifiedin Vivoin the Zebrafish Ovary

Generation of Bimaternal and Bipaternal Mice from Hypomethylated Haploid ESCs with Imprinting Region Deletions.

Offspring production of haploid spermatid-like cells derived from mouse female germline stem cells with chromatin condensation

The genetic program of oocytes can be modified in vivo in the zebrafish ovary.

Functional Oocytes Derived from Granulosa Cells.

In vitro fertilisation of mouse oocytes reconstructed by transfer of metaphase II chromosomes results in live births

Cross Species Fertilization and Development Investigated by Cat Sperm Injection into Mouse Oocytes

Totipotency of mouse zygotes extends to single blastomeres of embryos at the four-cell stage

Complete in vitro generation of fertile oocytes from mouse primordial germ cells

Production of Transgenic Mice by Random Recombination of Targeted Genes in Female Germline Stem Cells.

[Imprinting Genes Modified Parthenogenetic Embryonic Stem Cells Produce Full-Term Mouse Via Tetraploid Complementation].

Production of Non-Mosaic Genome Edited Porcine Embryos by Injection of CRISPR/Cas9 into Germinal Vesicle Oocytes.